300 related articles for article (PubMed ID: 3960417)
1. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA
Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
[TBL] [Abstract][Full Text] [Related]
2. The prognostic importance of steroid receptors in endometrial carcinoma.
Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
[TBL] [Abstract][Full Text] [Related]
3. [Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma--relation between clinical aspects and histopathology].
Gao YL
Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):451-4. PubMed ID: 3836850
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone receptors in uterine sarcomas.
Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
[TBL] [Abstract][Full Text] [Related]
5. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
[TBL] [Abstract][Full Text] [Related]
6. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
7. [Estrogen and progesterone receptors in corpus uteri carcinoma and their clinical significance].
Kleine W; Fuchs A; deGregorio G; Geyer H
Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):884-7. PubMed ID: 6925560
[TBL] [Abstract][Full Text] [Related]
8. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma.
Creasman WT; Soper JT; McCarty KS; McCarty KS; Hinshaw W; Clarke-Pearson DL
Am J Obstet Gynecol; 1985 Apr; 151(7):922-32. PubMed ID: 3985057
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma: clinical and histopathologic correlates.
Gao YL; Twiggs LB; Leung BS; Yu WC; Potish RA; Okagaki T; Adcock LL; Prem KA
Am J Obstet Gynecol; 1983 Jun; 146(3):299-306. PubMed ID: 6859140
[TBL] [Abstract][Full Text] [Related]
10. Steroid hormone receptor content and lymph node status in endometrial cancer.
Morris PC; Anderson JR; Anderson B; Buller RE
Gynecol Oncol; 1995 Mar; 56(3):406-11. PubMed ID: 7705676
[TBL] [Abstract][Full Text] [Related]
11. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
Ciocca DR; Puy LA; Fasoli LC
Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
[TBL] [Abstract][Full Text] [Related]
12. Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor.
Segreti EM; Novotny DB; Soper JT; Mutch DG; Creasman WT; McCarty KS
Obstet Gynecol; 1989 May; 73(5 Pt 1):780-5. PubMed ID: 2704506
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.
Kurebayashi J; Ishida T; Higashi Y; Suemasu K; Nomoto C; Yoshida K
Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
[TBL] [Abstract][Full Text] [Related]
15. Influence of "nuclear" estrogen receptor content on prognosis of early stage carcinoma of the uterine body. A short-time follow-up.
Horvath G; Johnsson JE; Tropé C; Samuelsson L; Alm P; Olsson H
Neoplasma; 1990; 37(1):43-6. PubMed ID: 2320180
[TBL] [Abstract][Full Text] [Related]
16. Sex steroid receptors in endometrial cancer.
Chambers JT
Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM
Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
[TBL] [Abstract][Full Text] [Related]
19. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC
Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma].
Hatae M; Yagi Y
Gan No Rinsho; 1983 Dec; 29(15):1740-9. PubMed ID: 6199529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
